English
Home > Products > 1-(2-isopropylthiazol-4-yl

China 1-(2-isopropylthiazol-4-yl Factory

Our commission is to serve our users and clients with best quality and competitive portable digital products for 1-(2-isopropylthiazol-4-yl,CAS NO 1185167-55-8,1185167-55-8,4-yl-N-MethylMethanaMine, We sincerely assume exchange and cooperation along with you. Let's move forward hand in hand and achieve win-win problem.
1-(2-isopropylthiazol-4-yl, We put the product quality and customer's benefits to the first place. Our experienced salesmen supply prompt and efficient service. Quality control group make sure the best quality. We believe quality comes from detail. If you have demand, allow us to work together to get success.

Related Products

Hot Products

  • alpha-Methylcinnamaldehyde

    alpha-Methylcinnamaldehyde

    Product Name:alpha-Methylcinnamaldehyde
    Molecular Formula:C10H10O
    Molecular Weight:146.19
    CAS Registry Number:101-39-3
  • 2-Nitrophenol

    2-Nitrophenol

    Product Name:2-Nitrophenol
    Molecular Formula:C6H5NO3
    Molecular Weight:139.11
    CAS Registry Number:88-75-5
  • Fmoc-Lys(Boc)-OH

    Fmoc-Lys(Boc)-OH

    Product Name:Fmoc-Lys(Boc)-OH
    Molecular Formula:C26H32N2O6
    Molecular Weight:468.54
    CAS Registry Number:71989-26-9
  • M-Toluic Acid

    M-Toluic Acid

    Product Name:M-Toluic Acid
    Molecular Weight:136.15
    CAS Registry Number:99-04-7
  • Anecortave Acetate

    Anecortave Acetate

    Product Name:Anecortave Acetate
    Molecular Formula:C23H30O5
    Molecular Weight:386.48
    CAS Registry Number;7753-60-8
  • Ticagrelor

    Ticagrelor

    Product Name:Ticagrelor
    Molecular Formula:C23H28F2N6O4S
    Molecular Weight:522.57
    CAS Registry Number:274693-27-5
  • Related Blog
  • Reviews

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept